Cargando…
A Prospective Randomized Double-Blind Study Evaluating UP165 and S-Adenosyl-l-Methionine on Depression, Anxiety and Psychological Well-Being
The primary objective of this pilot clinical trial was to evaluate the effects of UP165 (derived from Zea mays L., commonly known as corn) over time. The secondary objective was the comparison for outcomes versus S-adenosyl-methionine (SAM-e). Subjects with mild depression or anxiety were given the...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302331/ https://www.ncbi.nlm.nih.gov/pubmed/28231193 http://dx.doi.org/10.3390/foods4020130 |
_version_ | 1782506520083169280 |
---|---|
author | Kalman, Douglas S. Feldman, Samantha Rivas Vazquez, Rafeal Krieger, Diane R. |
author_facet | Kalman, Douglas S. Feldman, Samantha Rivas Vazquez, Rafeal Krieger, Diane R. |
author_sort | Kalman, Douglas S. |
collection | PubMed |
description | The primary objective of this pilot clinical trial was to evaluate the effects of UP165 (derived from Zea mays L., commonly known as corn) over time. The secondary objective was the comparison for outcomes versus S-adenosyl-methionine (SAM-e). Subjects with mild depression or anxiety were given the Beck Depression Inventory second edition (BDI-II), the Beck Anxiety Inventory (BAI), and the Schwartz Outcome Scale (SOS-10). Forty-two subjects (21–65 years old) were randomized to eight-weeks of supplementation with UP165 or SAM-e with questionnaires being administered at randomization, week four and eight. Those receiving UP165 achieved significant reduction from baseline at weeks four and eight, respectively for the BDI-II, as well as a trend for reduction in BAI at week four and significance at week eight. There was a trend for improvement on the SOS at week four and significance at week eight. SAM-e demonstrated a trend for improvement on the BDI-II by week eight over the UP165 with no differences between the two for the BAI or the SOS. Overall, this study indicates that there may be benefit to UP165 for mood enhancement in those with mild depression or anxiety. Randomized placebo comparator trials appear warranted. |
format | Online Article Text |
id | pubmed-5302331 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-53023312017-02-15 A Prospective Randomized Double-Blind Study Evaluating UP165 and S-Adenosyl-l-Methionine on Depression, Anxiety and Psychological Well-Being Kalman, Douglas S. Feldman, Samantha Rivas Vazquez, Rafeal Krieger, Diane R. Foods Article The primary objective of this pilot clinical trial was to evaluate the effects of UP165 (derived from Zea mays L., commonly known as corn) over time. The secondary objective was the comparison for outcomes versus S-adenosyl-methionine (SAM-e). Subjects with mild depression or anxiety were given the Beck Depression Inventory second edition (BDI-II), the Beck Anxiety Inventory (BAI), and the Schwartz Outcome Scale (SOS-10). Forty-two subjects (21–65 years old) were randomized to eight-weeks of supplementation with UP165 or SAM-e with questionnaires being administered at randomization, week four and eight. Those receiving UP165 achieved significant reduction from baseline at weeks four and eight, respectively for the BDI-II, as well as a trend for reduction in BAI at week four and significance at week eight. There was a trend for improvement on the SOS at week four and significance at week eight. SAM-e demonstrated a trend for improvement on the BDI-II by week eight over the UP165 with no differences between the two for the BAI or the SOS. Overall, this study indicates that there may be benefit to UP165 for mood enhancement in those with mild depression or anxiety. Randomized placebo comparator trials appear warranted. MDPI 2015-05-08 /pmc/articles/PMC5302331/ /pubmed/28231193 http://dx.doi.org/10.3390/foods4020130 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kalman, Douglas S. Feldman, Samantha Rivas Vazquez, Rafeal Krieger, Diane R. A Prospective Randomized Double-Blind Study Evaluating UP165 and S-Adenosyl-l-Methionine on Depression, Anxiety and Psychological Well-Being |
title | A Prospective Randomized Double-Blind Study Evaluating UP165 and S-Adenosyl-l-Methionine on Depression, Anxiety and Psychological Well-Being |
title_full | A Prospective Randomized Double-Blind Study Evaluating UP165 and S-Adenosyl-l-Methionine on Depression, Anxiety and Psychological Well-Being |
title_fullStr | A Prospective Randomized Double-Blind Study Evaluating UP165 and S-Adenosyl-l-Methionine on Depression, Anxiety and Psychological Well-Being |
title_full_unstemmed | A Prospective Randomized Double-Blind Study Evaluating UP165 and S-Adenosyl-l-Methionine on Depression, Anxiety and Psychological Well-Being |
title_short | A Prospective Randomized Double-Blind Study Evaluating UP165 and S-Adenosyl-l-Methionine on Depression, Anxiety and Psychological Well-Being |
title_sort | prospective randomized double-blind study evaluating up165 and s-adenosyl-l-methionine on depression, anxiety and psychological well-being |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302331/ https://www.ncbi.nlm.nih.gov/pubmed/28231193 http://dx.doi.org/10.3390/foods4020130 |
work_keys_str_mv | AT kalmandouglass aprospectiverandomizeddoubleblindstudyevaluatingup165andsadenosyllmethionineondepressionanxietyandpsychologicalwellbeing AT feldmansamantha aprospectiverandomizeddoubleblindstudyevaluatingup165andsadenosyllmethionineondepressionanxietyandpsychologicalwellbeing AT rivasvazquezrafeal aprospectiverandomizeddoubleblindstudyevaluatingup165andsadenosyllmethionineondepressionanxietyandpsychologicalwellbeing AT kriegerdianer aprospectiverandomizeddoubleblindstudyevaluatingup165andsadenosyllmethionineondepressionanxietyandpsychologicalwellbeing AT kalmandouglass prospectiverandomizeddoubleblindstudyevaluatingup165andsadenosyllmethionineondepressionanxietyandpsychologicalwellbeing AT feldmansamantha prospectiverandomizeddoubleblindstudyevaluatingup165andsadenosyllmethionineondepressionanxietyandpsychologicalwellbeing AT rivasvazquezrafeal prospectiverandomizeddoubleblindstudyevaluatingup165andsadenosyllmethionineondepressionanxietyandpsychologicalwellbeing AT kriegerdianer prospectiverandomizeddoubleblindstudyevaluatingup165andsadenosyllmethionineondepressionanxietyandpsychologicalwellbeing |